Table of Content

Chapter 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

Chapter 2:EXECUTIVE SUMMARY

2.1.CXO perspective

Chapter 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top Player Positioning
3.4.Porter’s five forces analysis
3.5.COVID-19 impact on the market
3.6.Government regulations

3.6.1.U.S. FDA

3.7.Reimbursement scenarios
3.8.Clinical trials
3.9.Patent analysis

3.9.1.Patents Registered/Approved, 2011–2020
3.9.2.Patents Registered/Approved, by Applicants, 2011–2020
3.9.3.U.S. patent analysis, by market applicants

3.10.Market Dynamics

3.10.1.Drivers

3.10.1.1.Rise in prevalence of lifestyle diseases
3.10.1.2.Increase in geriatric population
3.10.1.3.Rise in the adoption of remote patient monitoring devices

3.10.2.Restraints

3.10.2.1.Government regulations and reimbursement issues
3.10.2.2.Limited awareness and high costs

3.10.3.Opportunities

3.10.3.1.Technological advancements

Chapter 4:PATIENT MONITORING SYSTEMS MARKET, BY COMPONENT

4.1.Overview

4.1.1.Market size and forecast

4.2.Device

4.2.1.Market size and forecast
4.2.2.Hemodynamic monitoring devices

4.2.2.1.Key market trends and opportunity
4.2.2.2.Market size and forecast

4.2.3.Neuromonitoring devices

4.2.3.1.Key market trends and opportunities
4.2.3.2.Market size and forecast

4.2.4.Cardiac monitoring devices

4.2.4.1.Key market trends and opportunities
4.2.4.2.Market size and forecast

4.2.5.Fetal neonatal monitoring devices

4.2.5.1.Key market trends and opportunities
4.2.5.2.Market size and forecast

4.2.6.Respiratory monitors

4.2.6.1.Key market trends and opportunities
4.2.6.2.Market size and forecast

4.2.7.Multiparameter monitoring devices

4.2.7.1.Key market trends and opportunities
4.2.7.2.Market size and forecast

4.2.8.Remote patient monitoring devices

4.2.8.1.Key market trends and opportunities
4.2.8.2.Market size and forecast

4.2.9.Weight monitoring devices

4.2.9.1.Key market trends and opportunities
4.2.9.2.Market size and forecast

4.2.10.Temperature monitoring devices

4.2.10.1.Key market trends and opportunities
4.2.10.2.Market size and forecast

4.2.11.Urine output monitoring

4.2.11.1.Key market trends and opportunities
4.2.11.2.Market size and forecast

4.3.Service

4.3.1.Market size and forecast
4.3.2.Consulting

4.3.2.1.Market size and forecast

4.3.3.System Integration and Deployment

4.3.3.1.Market size and forecast

4.3.4.Support and Maintenance

4.3.4.1.Market size and forecast

4.4.Connectivity Technology

4.4.1.Cellular IoT - 3G

4.4.1.1.Market size and forecast

4.4.2.Cellular IoT - 4G

4.4.2.1.Market size and forecast

4.4.3.Wi-Fi

4.4.3.1.Market size and forecast

4.4.4.SIGFOX

4.4.4.1.Market size and forecast

4.4.5.Wireline

4.4.5.1.Market size and forecast

4.4.6.Wireless Personal Area Network (WPAN)

4.4.6.1.Market size and forecast

4.4.7.Others

4.4.7.1.Market size and forecast

Chapter 5:COMPANY PROFILES

5.1.ABBOTT LABORATORIES

5.1.1.Company overview
5.1.2.Company snapshot
5.1.3.Operating business segments
5.1.4.Product portfolio
5.1.5.Business performance
5.1.6.Key strategic moves and developments

5.2.BIOTRONIK SE & CO. KG

5.2.1.Company overview
5.2.2.Company snapshot
5.2.3.Operating business segments
5.2.4.Product portfolio
5.2.5.Key strategic moves and developments

5.3.BOSTON SCIENTIFIC CORPORATION

5.3.1.Company overview
5.3.2.Company snapshot
5.3.3.Operating business segments
5.3.4.Product portfolio
5.3.5.Business performance
5.3.6.Key strategic moves and developments

5.4.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

5.4.1.Company overview
5.4.2.Company snapshot
5.4.3.Operating business segments
5.4.4.Product portfolio
5.4.5.Business performance
5.4.6.Key strategic moves and developments

5.5.F. HOFFMANN-LA ROCHE LTD.

5.5.1.Company overview
5.5.2.Company snapshot
5.5.3.Operating business segments
5.5.4.Product portfolio
5.5.5.Business performance
5.5.6.Key strategic moves and developments

5.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

5.6.1.Company overview
5.6.2.Company snapshot
5.6.3.Operating business segments
5.6.4.Product portfolio
5.6.5.Business performance
5.6.6.Key strategic moves and developments

5.7.MASIMO CORPORATION

5.7.1.Company overview
5.7.2.Company snapshot
5.7.3.Product portfolio
5.7.4.Business performance
5.7.5.Key Strategic Moves and Developments

5.8.MEDTRONIC PLC.

5.8.1.Company overview
5.8.2.Company snapshot
5.8.3.Operating business segments
5.8.4.Medtronic offers following patient monitoring devices
5.8.5.Business performance
5.8.6.Key strategic moves and developments

5.9.NIHON KOHDEN CORPORATION

5.9.1.Company overview
5.9.2.Company snapshot
5.9.3.Operating business segments
5.9.4.Product portfolio
5.9.5.Business performance
5.9.6.Key strategic moves and developments

5.10.OSI Systems, Inc. (Spacelabs Healthcare)

5.10.1.Company overview
5.10.2.Company snapshot
5.10.3.Operating business segments
5.10.4.Product portfolio
5.10.5.Business performance
5.10.6.Key Strategic Moves and Development



List of Figures



FIGURE 01.TOP INVESTMENT POCKETS: U.S. PATIENT MONITORING SYSTEMS MARKET, BY DEVICE TYPE
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020* (%)
FIGURE 05.TOP PLAYER POSITIONING
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.PATENTS REGISTERED/APPROVED, 2011–2020
FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 14.HEMODYNAMIC MONITORING DEVICES MARKET, 2019-2027
FIGURE 15.NEUROMONITORING DEVICE MARKET, 2019-2027
FIGURE 16.CARDIAC MONITORING DEVICES MARKET, 2019-2027
FIGURE 17.FETAL AND NEONATAL MONITORING DEVICES MARKET, 2019-2027
FIGURE 18.RESPIRATORY MONITORS MARKET, 2019-2027
FIGURE 19.MULTIPARAMETER MONITORING DEVICES MARKET, 2019-2027
FIGURE 20.REMOTE PATIENT MONITORING DEVICES MARKET, 2019-2027
FIGURE 21.WEIGHT MONITORING DEVICES MARKET, 2019-2027
FIGURE 22.TEMPERATURE MONITORING DEVICES MARKET, 2019-2027
FIGURE 23.URINE OUTPUT MONITORING DEVICES MARKET, 2019-2027
FIGURE 24.PATIENT MONITORING SYSTEMS MARKET FOR CONSULTING, 2019-2027
FIGURE 25.PATIENT MONITORING SYSTEMS MARKET FOR SYSTEM INTEGRATION AND DEPLOYMENT, 2019-2027
FIGURE 26.PATIENT MONITORING SYSTEMS MARKET FOR SUPPORT AND MAINTENANCE, 2019-2027
FIGURE 27.PATIENT MONITORING SYSTEMS MARKET FOR CELLULAR IOT - 3G, 2019-2027
FIGURE 28.PATIENT MONITORING SYSTEMS MARKET FOR CELLULAR IOT - 4G, 2019-2027
FIGURE 29.PATIENT MONITORING SYSTEMS MARKET FOR WI-FI, 2019-2027
FIGURE 30.PATIENT MONITORING SYSTEMS MARKET FOR SIGFOX, 2019-2027
FIGURE 31.PATIENT MONITORING SYSTEMS MARKET FOR WIRELINE, 2019-2027
FIGURE 32.PATIENT MONITORING SYSTEMS MARKET FOR WIRELESS PERSONAL AREA NETWORK (WPAN), 2019-2027
FIGURE 33.PATIENT MONITORING SYSTEMS MARKET FOR OTHERS, 2019-2027
FIGURE 34.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 36.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 37.BOSTON SCIENTIFIC CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.GE: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.GE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 49.MASIMO: NET SALES, 2017-2019 ($MILLION)
FIGURE 50.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54.NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 55.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)
FIGURE 56.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 57.OSI SYSTEMS: NET SALES, 2016–2018 ($MILLION)
FIGURE 58.OSI SYSTEMS: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 59.OSI SYSTEMS: REVENUE SHARE, BY REGION, 2018 (%)


List of Tables



TABLE 01.CLINICAL TRIALS: PATIENT MONITORING SYSTEMS MARKET, 2013–2020
TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011–2020
TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
TABLE 05.U.S. PATIENT MONITORING SYSTEMS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 06.U.S. PATIENT MONITORING SYSTEMS MARKET, BY DEVICE TYPE, 2019–2027 ($MILLION)
TABLE 07.U.S. PATIENT MONITORING SYSTEMS MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)
TABLE 08.ABBOTT: COMPANY SNAPSHOT
TABLE 09.ABBOTT: OERATING SEGMENT
TABLE 10.ABBOTT: PRODUCT PORTFOLIO
TABLE 11.BIOTRONIK: COMPANY SNAPSHOT
TABLE 12.BIOTRONIK: OPERATING SEGMENTS
TABLE 13.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 14.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 15.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 16.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 17.GE: COMPANY SNAPSHOT
TABLE 18.GE: OPERATING SEGMENTS
TABLE 19.GE: PRODUCT PORTFOLIO
TABLE 20.ROCHE: COMPANY SNAPSHOT
TABLE 21.ROCHE: OERATING SEGMENT
TABLE 22.ROCHE: PRODUCT PORTFOLIO
TABLE 23.PHILIPS: COMPANY SNAPSHOT
TABLE 24.PHILIPS: OPERATING SEGMENTS
TABLE 25.PHILIPS: PRODUCT PORTFOLIO
TABLE 26.MASIMO: COMPANY SNAPSHOT
TABLE 27.MASIMO: PRODUCT PORTFOLIO
TABLE 28.MEDTRONIC: COMPANY SNAPSHOT
TABLE 29.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 30.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 31.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 32.NIHON KOHDEN: PRODUCT PORTFOLIO
TABLE 33.OSI SYSTEMS: COMPANY SNAPSHOT
TABLE 34.OSI SYSTEMS: OPERATING SEGMENTS
TABLE 35.OSI SYSTEMS: PRODUCT PORTFOLIO